Sai Parenterals' subsidiary, Noumed Pharmaceuticals, renewed a 3-year OTC Medicines Supply Agreement with an Australian pharmacy chain, valued at approximately ₹204 Crore.
Sai Parenterals secured a ₹104.50 Crore exclusive anti-TB product supply contract from Philippines-based PILL CORP. The ten-year agreement provides significant long-term revenue visibility and international market expansion.